Trials / Completed
CompletedNCT02942888
The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition
The Effects of NAD on Brain Function and Cognition
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effects of Niagen (nicotinamide riboside, vitamin B3), on NAD levels, brain function including cognition and blood flow in people diagnosed with mild cognitive impairment (MCI).
Detailed description
Niagen is a patented formula which is the first and only commercially available form of Nicotinamide Riboside (NR). It has been proven in basic science studies as a highly effective NAD booster, but it also works as a vitamin B3 supplement. NAD helps pass energy from glucose to other pathways in the cell. Niagen (Nicotinamide Riboside, vitamin B3) is one of the most effective NAD+ precursors to support cellular health. The purpose of this study is to determine the effects of Niagen (nicotinamide riboside, vitamin B3), on NAD levels, brain function including cognition and blood flow in people diagnosed with mild cognitive impairment (MCI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nicotinamide riboside | Oral administration of Niagen ramp up 250mg to 1g/day as tolerated |
| DIETARY_SUPPLEMENT | Sugar Pill | This is a placebo compounded by ChromaDex, Inc. |
Timeline
- Start date
- 2017-11-30
- Primary completion
- 2019-08-31
- Completion
- 2021-08-16
- First posted
- 2016-10-24
- Last updated
- 2021-09-02
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02942888. Inclusion in this directory is not an endorsement.